Paxlovid may temporarily reduce the efficacy of combined contraceptives. While evidence is limited, it’s safest to consider using a backup method of contraception while taking Paxlovid. Paxlovid ...

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate ...

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older ...

Prescribing guidelines and the benefits and risks of nirmatrelvir/ritonavir for COVID patients ...

Demand for the drugmaker’s Paxlovid treatment spurred by the latest COVID wave and a U.S. national stockpile delivery led to $2.7 billion in sales for the drug, Pfizer said Tuesday. The company ...

Demand for the drugmaker’s Paxlovid treatment spurred by the latest COVID wave and a U.S. national stockpile delivery led to $2.7 billion in sales for the drug, Pfizer said Tuesday. The company also ...

Pfizer's COVID revenues include direct sales and alliance revenues from its partner, BioNTech BNTX, for Comirnaty and product revenues from its oral antiviral pill for COVID-19, Paxlovid.

Anticipated revenues for Comirnaty and Paxlovid, approximately $5 billion and $5.5 billion in 2024. Pfizer expects full-year 2024 operational revenue growth of 9% to 11% compared to 2023 revenue.

PETALING JAYA: The antiviral drug Paxlovid is available for free for Covid-19 patients at private health facilities and government health clinics, which will help with the rising Covid-19 cases in ...